Viewing Study NCT02556892

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2026-06-25 @ 6:11 PM
Study NCT ID: NCT02556892
Status: COMPLETED
Last Update Posted: 2019-08-14
First Post: 2015-06-30
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Treatment-naive Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
Sponsor: Janssen Pharmaceutical K.K.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Lymphocytic Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Lymphocytic Leukemia View
None Ibrutinib View
None PCI-32765 View
None JNJ-54179060 View